These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15155834)

  • 1. Interaction of heterogeneous nuclear ribonucleoprotein A1 with cytochrome P450 2A6 mRNA: implications for post-transcriptional regulation of the CYP2A6 gene.
    Christian K; Lang M; Maurel P; Raffalli-Mathieu F
    Mol Pharmacol; 2004 Jun; 65(6):1405-14. PubMed ID: 15155834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between hnRNP A1 and a cis-acting element in the 3' UTR of CYP2A5 mRNA is central for high expression of the gene.
    Glisovic T; Ben-David Y; Lang MA; Raffalli-Mathieu F
    FEBS Lett; 2003 Jan; 535(1-3):147-52. PubMed ID: 12560094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous nuclear ribonucleoprotein A1 and regulation of the xenobiotic-inducible gene Cyp2a5.
    Raffalli-Mathieu F; Glisovic T; Ben-David Y; Lang MA
    Mol Pharmacol; 2002 Apr; 61(4):795-9. PubMed ID: 11901218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of RNA-protein interactions of mouse liver cytochrome P4502A5 mRNA.
    Tilloy-Ellul A; Raffalli-Mathieu F; Lang MA
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):695-703. PubMed ID: 10215609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a 43-kDa protein in human liver cytosol that binds to the 3'-untranslated region of CYP2A6 mRNA.
    Gilmore J; Rotondo F; Pelletier AM; LaMarre J; Alaoui-Jamali M; Kirby GM
    Biochem Pharmacol; 2001 Sep; 62(6):669-78. PubMed ID: 11551511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between transcriptional and post-transcriptional regulation of Cyp2a5 expression.
    Glisovic T; Söderberg M; Christian K; Lang M; Raffalli-Mathieu F
    Biochem Pharmacol; 2003 May; 65(10):1653-61. PubMed ID: 12754101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression.
    Wang J; Pitarque M; Ingelman-Sundberg M
    Biochem Biophys Res Commun; 2006 Feb; 340(2):491-7. PubMed ID: 16378601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-mediated down-regulation of rat beta1-adrenergic receptor transcripts: role of potential post-transcriptional degradation factors.
    Kirigiti P; Bai Y; Yang YF; Li X; Li B; Brewer G; Machida CA
    Mol Pharmacol; 2001 Dec; 60(6):1308-24. PubMed ID: 11723238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA.
    Huang P; Lai MM
    J Virol; 2001 Jun; 75(11):5009-17. PubMed ID: 11333880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Cyp2a5 transcription in mouse primary hepatocytes: roles of hepatocyte nuclear factor 4 and nuclear factor I.
    Ulvila J; Arpiainen S; Pelkonen O; Aida K; Sueyoshi T; Negishi M; Hakkola J
    Biochem J; 2004 Aug; 381(Pt 3):887-94. PubMed ID: 15115437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2A7 pseudogene transcript affects CYP2A6 expression in human liver by acting as a decoy for miR-126.
    Nakano M; Fukushima Y; Yokota S; Fukami T; Takamiya M; Aoki Y; Yokoi T; Nakajima M
    Drug Metab Dispos; 2015 May; 43(5):703-12. PubMed ID: 25710939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNP A1 mediates the activation of the IRES-dependent SREBP-1a mRNA translation in response to endoplasmic reticulum stress.
    Damiano F; Rochira A; Tocci R; Alemanno S; Gnoni A; Siculella L
    Biochem J; 2013 Jan; 449(2):543-53. PubMed ID: 23106379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.
    Abu-Bakar A; Hakkola J; Juvonen R; Rahnasto-Rilla M; Raunio H; Lang MA
    Curr Drug Metab; 2013 Jan; 14(1):137-50. PubMed ID: 22497566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding proteins heterogeneous nuclear ribonucleoprotein A1, E1, and K are involved in post-transcriptional control of collagen I and III synthesis.
    Thiele BJ; Doller A; Kähne T; Pregla R; Hetzer R; Regitz-Zagrosek V
    Circ Res; 2004 Nov; 95(11):1058-66. PubMed ID: 15514164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of CYP2A5 gene by the transcription factor nuclear factor (erythroid-derived 2)-like 2.
    Abu-Bakar A; Lämsä V; Arpiainen S; Moore MR; Lang MA; Hakkola J
    Drug Metab Dispos; 2007 May; 35(5):787-94. PubMed ID: 17303623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the human CYP2A6 gene.
    Pitarque M; Rodríguez-Antona C; Oscarson M; Ingelman-Sundberg M
    J Pharmacol Exp Ther; 2005 May; 313(2):814-22. PubMed ID: 15671201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.
    Pitarque M; von Richter O; Rodríguez-Antona C; Wang J; Oscarson M; Ingelman-Sundberg M
    Hum Mutat; 2004 Mar; 23(3):258-66. PubMed ID: 14974084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro.
    Yoshida R; Nakajima M; Nishimura K; Tokudome S; Kwon JT; Yokoi T
    Clin Pharmacol Ther; 2003 Jul; 74(1):69-76. PubMed ID: 12844137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter.
    Onica T; Nichols K; Larin M; Ng L; Maslen A; Dvorak Z; Pascussi JM; Vilarem MJ; Maurel P; Kirby GM
    Mol Pharmacol; 2008 Feb; 73(2):451-60. PubMed ID: 17978169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6).
    von Richter O; Pitarque M; Rodríguez-Antona C; Testa A; Mantovani R; Oscarson M; Ingelman-Sundberg M
    Pharmacogenetics; 2004 Jun; 14(6):369-79. PubMed ID: 15247629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.